1.8800
+0.0300
+(1.62%)
At close: March 3 at 12:06:25 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-110,688.4290
-124,365.5510
-216,215.4210
-215,708.5250
-177,979.0460
Investing Cash Flow
89,369.9940
87,355.8750
109,585.8560
-175,344.4840
-58,795.7510
Financing Cash Flow
24,168.4270
4,995.0990
81,840.7020
211,498.8030
465,279.6130
End Cash Position
21,654.5940
14,310.8620
46,329.3590
71,143.7780
250,728.1180
Income Tax Paid Supplemental Data
--
--
1,066.9750
1,077.8030
4,624.7640
Interest Paid Supplemental Data
533.4870
1,066.9750
1,066.9750
1,077.8030
4,624.7640
Capital Expenditure
-487.8320
-320.8980
-969.1530
-1,231.0060
-1,520.6650
Issuance of Capital Stock
24,790.1500
5,461.7450
82,955.3110
209,441.4100
454,486.4000
Issuance of Debt
--
--
--
--
171.6200
Free Cash Flow
-111,176.2610
-124,686.4490
-217,184.5740
-216,939.5310
-179,499.7110
12/31/2020 - 4/7/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6XP.SG Xspray Pharma AB (publ)
2.7700
-0.36%
6XY.F HBM Holdings Limited
0.6450
+4.88%
CRO.BE Open Orphan PLC
0.1990
0.00%
8JD.F Valbiotis SA
1.2760
+1.11%
I5X.F Precigen, Inc.
1.6450
+4.58%
HPHA.F Heidelberg Pharma AG
2.6300
-5.73%
CRO.F hVIVO plc
0.1740
+4.82%
OPORF hVIVO plc
0.2400
-31.43%
8C5.F Coherus BioSciences, Inc.
1.0195
-0.44%
2LB.F Iovance Biotherapeutics, Inc.
3.8710
-2.32%